サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1768417

CRO（医薬品開発業務受託機関）サービスの世界市場

Contract Research Organization Services (CROs)

出版日
ページ情報
英文 803 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
CRO（医薬品開発業務受託機関）サービスの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 803 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

CRO（医薬品開発業務受託機関）サービスの世界市場は2030年までに1,491億米ドルに達する見込み

2024年に814億米ドルと推定されるCRO（医薬品開発業務受託機関）サービスの世界市場は、2024年から2030年にかけてCAGR 10.6%で成長し、2030年には1,491億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである臨床調査は、CAGR 11.4%を記録し、分析期間終了時には767億米ドルに達すると予測されます。初期段階開発セグメントの成長率は、分析期間中CAGR 10.5%と推定されます。

米国市場は324億米ドルと推定、中国はCAGR13.6%で成長予測

米国のCRO（医薬品開発業務受託機関）サービス市場は、2024年に324億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに101億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.7%と9.5%と予測されています。欧州では、ドイツがCAGR 10.6%で成長すると予測されています。

世界のCRO（医薬品開発業務受託機関）サービス市場- 主要動向と促進要因のまとめ

なぜCROは製薬・バイオ産業に不可欠なのか？

医薬品開発業務受託機関（CRO）は、創薬、研究開発、商品化をサポートする研究サービスのアウトソーシングを提供することで、製薬およびバイオテクノロジー産業において重要な役割を果たしています。CROは、臨床試験管理、前臨床研究、薬事、データ管理など幅広いサービスを提供しています。CROと提携することで、製薬企業やバイオテクノロジー企業は、専門的な知識、高度な技術、世界のリソースを利用することができ、新薬の開発を加速し、市場投入までの時間を短縮することができます。CROに研究活動を委託することで、企業はコアコンピタンスに集中し、業務を効率化することができ、CROは医薬品開発のエコシステムにとって不可欠な存在となっています。

CROサービス活用の利点と課題とは？

CROサービスを活用するメリットには、コスト削減、専門的な専門知識へのアクセス、業務効率の向上などがあります。CROはその規模と経験により、社内チームよりもコスト効率よく調査活動を行うことができます。また、臨床試験実施施設の世界ネットワークや規制に関する知識を利用できるため、多国籍臨床試験の実施が容易になり、規制要件の遵守が保証されます。しかし、CROへのアウトソーシングには、効果的なコミュニケーションと調整の必要性、データセキュリティへの潜在的リスク、調査の質と完全性の確保などの課題もあります。このような課題を軽減し、CROサービスのメリットを最大化するためには、強力なパートナーシップと明確な契約内容を確立することが不可欠です。

テクノロジーはCRO業界をどのように変革しているか？

テクノロジーはCRO業界を変革し、調査サービスの効率と質を高めています。高度なデータ分析、人工知能（AI）、機械学習は、臨床試験デザイン、患者募集、データ分析を最適化し、医薬品開発の時間とコストを削減するために利用されています。電子データ収集（EDC）システムと遠隔モニタリングツールは、データの精度を向上させ、臨床試験の進捗状況をリアルタイムで追跡できるようにしています。遠隔医療やウェアラブルデバイスに支えられた分散型臨床試験（DCT）モデルの採用は、特に遠隔地や十分なサービスを受けていない地域における患者の参加と関与を増加させています。このような技術の進歩は、CRO業界の技術革新を促進し、調査サービスの全体的な有効性を向上させています。

CRO市場の成長を促す要因とは？

CRO市場の成長は、いくつかの要因によってもたらされます。医薬品開発の複雑化とコストの増大により、製薬企業やバイオテクノロジー企業は研究活動をCROに委託するようになっています。データマネジメントとアナリティクスの技術的進歩により、CROサービスの能力と効率が向上しています。臨床試験の世界化と多様な規制要件を満たす必要性も、国際的な専門知識を持つCROへの需要を押し上げています。さらに、個別化医療の台頭、生物製剤や先端療法の開発は、これらの分野に特化したCROに新たな機会をもたらしています。これらの要因が相まって、CRO市場の継続的な成長と革新が確実なものとなっています。

セグメント

サービスタイプ（臨床研究、初期段階開発、ラボラトリー、その他サービスタイプ）;治療領域（がん、中枢神経系疾患、糖尿病、心血管疾患、代謝性疾患、感染症、その他治療領域）;エンドユーザー（製薬・バイオファーマ企業、医療機器企業、学術機関）

調査対象企業の例

  • 360biolabs（R）
  • Charles River Laboratories International Inc.
  • ICON plc
  • IQVIA, Inc.
  • KCR S.A
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PSI CRO AG
  • Syneos Health, Inc.
  • WuXi AppTec

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • インド
  • その他アジア太平洋地域
  • ラテンアメリカ
  • その他の地域

第4章 競合

目次
Product Code: MCP21551

Global Contract Research Organization Services (CROs) Market to Reach US$149.1 Billion by 2030

The global market for Contract Research Organization Services (CROs) estimated at US$81.4 Billion in the year 2024, is expected to reach US$149.1 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 Billion by the end of the analysis period. Growth in the Early Phase Development segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.4 Billion While China is Forecast to Grow at 13.6% CAGR

The Contract Research Organization Services (CROs) market in the U.S. is estimated at US$32.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Contract Research Organization Services (CROs) Market - Key Trends & Drivers Summarized

Why Are CROs Vital in the Pharmaceutical and Biotechnology Industries?

Contract Research Organizations (CROs) play a crucial role in the pharmaceutical and biotechnology industries by providing outsourced research services that support drug discovery, development, and commercialization. CROs offer a wide range of services, including clinical trial management, preclinical research, regulatory affairs, and data management. By partnering with CROs, pharmaceutical and biotech companies can access specialized expertise, advanced technologies, and global resources, accelerating the development of new therapies and reducing time-to-market. The ability to outsource research activities to CROs allows companies to focus on their core competencies and streamline their operations, making CROs an indispensable part of the drug development ecosystem.

What Are the Benefits and Challenges of Utilizing CRO Services?

The benefits of utilizing CRO services include cost savings, access to specialized expertise, and improved operational efficiency. CROs can conduct research activities more cost-effectively than in-house teams due to their scale and experience. They also provide access to a global network of clinical sites and regulatory knowledge, facilitating the conduct of multinational clinical trials and ensuring compliance with regulatory requirements. However, there are challenges associated with outsourcing to CROs, such as the need for effective communication and coordination, potential risks to data security, and ensuring the quality and integrity of research. Establishing strong partnerships and clear contractual agreements is essential to mitigate these challenges and maximize the benefits of CRO services.

How Is Technology Transforming the CRO Industry?

Technology is transforming the CRO industry, enhancing the efficiency and quality of research services. Advanced data analytics, artificial intelligence (AI), and machine learning are being used to optimize clinical trial design, patient recruitment, and data analysis, reducing the time and cost of drug development. Electronic data capture (EDC) systems and remote monitoring tools are improving data accuracy and enabling real-time tracking of clinical trial progress. The adoption of decentralized clinical trial (DCT) models, supported by telemedicine and wearable devices, is increasing patient participation and engagement, particularly in remote or underserved regions. These technological advancements are driving innovation in the CRO industry and improving the overall effectiveness of research services.

What Factors Are Driving the Growth in the CRO Market?

The growth in the CRO market is driven by several factors. The increasing complexity and cost of drug development are prompting pharmaceutical and biotechnology companies to outsource research activities to CROs. Technological advancements in data management and analytics are enhancing the capabilities and efficiency of CRO services. The globalization of clinical trials and the need to meet diverse regulatory requirements are also boosting demand for CROs with international expertise. Additionally, the rise of personalized medicine and the development of biologics and advanced therapies are creating new opportunities for CROs specializing in these areas. These factors collectively ensure the continued growth and innovation in the CRO market.

SCOPE OF STUDY:

The report analyzes the Contract Research Organization Services (CROs) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Clinical Research, Early Phase Development, Laboratory, Other Service Types); Therapeutic Area (Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Other Therapeutic Areas); End-Use (Pharma & Biopharma Companies, Medical Device Companies, Academic Institutes)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 307 Featured) -

  • 360biolabs(R)
  • Charles River Laboratories International Inc.
  • ICON plc
  • IQVIA, Inc.
  • KCR S.A
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PSI CRO AG
  • Syneos Health, Inc.
  • WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Contract Research Outsourcing: An Introduction
    • Qualities that have to be considered while selecting a CRO
    • Global Economic Update
    • Tariff Impact on Global Supply Chain Patterns
    • Competition
    • M&A Activity Rampant in the CRO Market
    • M&A Activity Yields Immense Pressure on Smaller CROs
    • Contract Research Organization Services (CROs) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Players Adapt & Align with Evolutionary Changes in CRO Industry
    • Global Market Prospects and Outlook
    • Global Contract Research Organization Services (CROs) Market Set for a Rapid Growth
    • Rapidly Changing & Evolving Landscape Entails Seismic Shifts for CROs
    • Stringent Regulations Fuel the Need for CROs
    • Technology Changes the Research Foot Prints of the CRO Industry
    • Market Outlook
    • Regional Market Analysis
    • Trend of Clinical Trials Outsourcing Attains Pace in North America
    • Digital Technology Facilitates Decentralized Trials
    • Key Trends in the CRO Market
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Rise in Pharmaceutical Sales to Drive Demand for CRO Services
    • Global Prescription Drug Sales (In US$ Trillion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Persistent Increase in Pharmaceutical R&D Bodes Well for CRO Market
    • Surge in Clinical Trials Powers Growth of CRO Industry
    • CROs to Leverage Artificial Intelligence in a Major Way to Increase Efficacy of Clinical Research
    • Pandemic Spawns Digitization Wave
    • CROs and the Emergence of New Technology: Opportunities and Challenges
    • Popularity of Wearable technology Eases Enlisting Study groups and Tracking of Patient Activity
    • Biosimulation Enhances Data Interpretation and Pre-Verification
    • CROs: From a Humble Beginning to Partners of Moment for Drug Discovery Endeavors
    • Biotechnology Firms as Valuable Options
    • CROs in Great Demand
    • CROs with Process Maturity in Demand
    • Dealing with Geopolitical Issues
    • Decentralized Clinical Trials & Flexibility
    • Issues with Hybrid Trials & Sponsor Preferences
    • CROs to Mitigate Supply Chain Glitches
    • Bio-Pharmaceutical Sector Regains Momentum Post Pandemic
    • Growing Size and Complexity of Clinical Trials Increase Biotech's Dependence on CROs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Contract Research Organization Services (CROs) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Contract Research Organization Services (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Early Phase Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Early Phase Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Early Phase Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for CNS Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Metabolic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Metabolic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Metabolic Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Contract Research Organization Services (CROs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for India and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 197: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of World Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of World 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of World Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of World 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of World Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of World 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION